Definity
Amyloidosis Cardiac
Brigham and Women's HospitalPhase 4 / ApprovedActive
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 47/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Amyloidosis Cardiac cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
cc-5013 Seoul National University Hospital | Phase 3 | B |
PANITUMUMAB Heinrich-Heine University, Duesseldorf | N/A | D |
Same molecule, other indications
Definity is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →